ARCHIVE

• Recall of Drugs Hits Record High: Korosho Data
  June 17, 2002

• Elk: Sales, Profit Down Due to Stiffer Competition for X-ray Films
  June 17, 2002

• Rohto: Net Profits Down Due to Slump of Eye Care Products
  June 17, 2002

• Difficulty Related to Pediatric Emergency Care Revealed: Survey
  June 17, 2002

• Spiriva Effects on COPD Reported
  June 17, 2002

• Zeria: Sales Down 3.5% to \53.8 Bil.
  June 17, 2002

• Quintiles to Conduct Clinical Trials on Japanese in Hawaii
  June 17, 2002

• Boehringer Ingelheim Obtains Approval for MicadisPlus in EU
  June 17, 2002

• Fuso: Stiffer Competition Squeezes Profits
  June 17, 2002

• REGULATORY NEWS IN BRIEF
  June 17, 2002

• Sanofi-Synthelabo Reports Hypotensive Effects of Irbesartan
  June 17, 2002

• Nippon Chemiphar: New Gout Treatment GL to Remarkably Boost Sales, Profits
  June 17, 2002

• If Generics Were 60% Cheaper, 22% of Patients Would Choose Them: Survey
  June 17, 2002

• Enrollment Completed for Major Int'l Stroke Prevention Trial: Sanofi-Sythelabo
  June 17, 2002

• Nissui: Sales, Profits Down Due to Slump of Diagnostics
  June 17, 2002

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  June 17, 2002

• Fondaparinux Prevents VTE after Hip Replacement Surgery
  June 17, 2002

• Morishita Jintan: 15.6% Drop in Sales, Net Loss of \953 Mil.
  June 17, 2002

• JSC to Draft Manual for Antibacterial Clinical Trials in Specific Disease States
  June 17, 2002

• Zoledronate Delays Onset of Cancer-related Bone Complications: Novartis
  June 17, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 672
• 673
• 674
• 675
• 676
• 677
• 678
• 679
• 680
• …
• Next ›
• 最終 »